Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Nkarta (NKTX)

Lambang korporat lan logo Nkarta Corp (NKTX)

The quarterly percentage growth in earnings per share reflects the dynamics of Nkarta, Inc. (NKTX), which develops affordable NK-cell therapies for the treatment of hematological malignancies. The development process is based on leveraging external laboratories while maintaining full ownership of intellectual property rights. High costs associated with safety and patents limit the entry of competitors, with the indicator reaching -52.10.

Nkarta (NKTX) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan saka 04.07.2022 nganti 16.11.2026

NKTX (nkartatx.com): rincian analitis lan laporan miturut indikator

- nilai pasar lan prakiraan target analis:
Analisis wiwitan perusahaan:Nkarta, Inc.
Produk asil prodhuksi Nkarta, Inc.

Defensive assets are typically characterized by stable cash flows and predictable returns. Nkarta, Inc. (NKTX) does not meet these criteria, as its value is based on the speculative potential of cancer treatment patents. This quarterly EPS growth rate measures earnings per share dynamics by interpolating infrequent reports into daily values. This calculation reveals seasonal cycles and the rate of change in business efficiency. Analysis of this chart allows for an assessment of how clinical trial results impact the company's fundamental value.

Karo sapa Nkarta, Inc. saingan

tgtherapeutics.com (TGTX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Arcellx Therapeutics (ACLX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Disc Medicine Inc|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Syndax Pharmaceuticals SNDX|Wutah bathi EPS kuartalan KURA|ADC Therapeutics SA - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan FHTX (Foghorn Therapeutics, Inc.)|Vor Bio Inc. (VOR) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|COEP - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Actinium Pharmaceuticals, Inc. (ATNM) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ESLA (Estrella Immunopharma) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CASI - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Marker Bio|Wutah bathi EPS kuartalan IN8bio, Inc.|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Eterna Therapeutics Inc (ERNA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan gtbiopharma.com|Wutah bathi EPS kuartalan APTO (Aptose Biosciences)|Wutah bathi EPS kuartalan Bio-Path BPTH|MEI Pharma Inc - Wutah bathi EPS kuartalan|VINC (Vincerx Pharma Inc.) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan